Abstract
Purpose
Since 2001, hypoglossal nerve stimulators have been implanted in patients with obstructive sleep apnea around the world, initially in trial situations but more recently also in regular care settings. Medium term data indicate effectiveness and tolerability of treatment. However, when assessing the safety of the procedure, the safe feasibility of explantation or reimplantation must also be considered.
Patients and methods
Nine patients with an implanted respiratory-driven hypoglossal nerve stimulator. We have evaluated the feasibility and safety of explantation or re-implantation with another stimulation system.
Results
In 2012, nine patients were implanted with a respiratory-driven hypoglossal nerve stimulator as part of the Apnex Medical Pivotal Study. The study was ended in 2013. For a variety of reasons, the system was explanted from all nine patients by the year 2019. Three of these patients were re-implanted with a different system with respiratory sensing during the same session (mean incision to closure time for explantation 88.2 ± 35.01 min., mean incision to closure time for re-implantation 221.75 ± 52.73 min.). Due to extensive scar tissue formation, all procedures were technically challenging. Complication rate was significantly higher when re-implantation was performed or attempted in the same surgical session (0 of 5 patients with explantation versus 3 of 4 patients with attempted re-implantation; p = 0.018). There was no significant difference between the AHI values before and after implantation in patients with re-implantation.
Conclusion
Explantation and re-implantation are technically challenging though possible procedures. The single-staged equilateral reimplantation of another hypoglossal nerve stimulation system can, but need not, be successful.
Similar content being viewed by others
Availability of data and material (data transparency)
All data and materials support the published claims and comply with field standards.
References
Zaidi FN, Meadows P, Jacobowitz O, Davidson TM (2012) Tongue anatomy and physiology, the scientific basis for a novel targeted neurostimulation system designed for the treatment of obstructive sleep apnea. Neuromodulation. https://doi.org/10.1111/j.1525-1403.2012.00514.x
Dedhia RC, Strollo PJ, Soose RJ, Soose RJ (2015) Upper airway stimulation for obstructive sleep apnea: past, present, and future. Sleep 38:899–906. https://doi.org/10.5665/sleep.4736
Certal VF, Zaghi S, Riaz M et al (2015) Hypoglossal nerve stimulation in the treatment of obstructive sleep apnea: a systematic review and meta-analysis. Laryngoscope 125:1254–1264. https://doi.org/10.1002/lary.25032
Eastwood PR, Barnes M, MacKay SG et al (2019) Bilateral hypoglossal nerve stimulation for treatment of adult obstructive sleep apnea. Eur Respir J. https://doi.org/10.1183/13993003.01320-2019
Schwartz AR, Bennett ML, Smith PL et al (2001) Therapeutic electrical stimulation of the hypoglossal nerve in obstructive sleep apnea. Arch Otolaryngol Neck Surg 127:1216. https://doi.org/10.1001/archotol.127.10.1216
Smith PL, Eisele DW, Podszus T et al (1996) Electrical stimulation of upper airway musculature. Sleep 19:S284–S287
Eisele DW, Smith PL, Alam DS, Schwartz AR (1997) Direct hypoglossal nerve stimulation in obstructive sleep apnea. Arch Otolaryngol Head Neck Surg 123:57–61
Boon M, Huntley C, Steffen A et al (2018) Upper airway stimulation for obstructive sleep apnea: results from the ADHERE Registry. Otolaryngol Neck Surg 159:379–385. https://doi.org/10.1177/0194599818764896
Steffen A, Sommer JU, Hofauer B et al (2018) Outcome after one year of upper airway stimulation for obstructive sleep apnea in a multicenter German post-market study. Laryngoscope 128:509–515. https://doi.org/10.1002/lary.26688
Strollo PJ, Soose RJ, Maurer JT et al (2014) Upper-airway stimulation for obstructive sleep apnea. N Engl J Med 370:139–149. https://doi.org/10.1056/NEJMoa1308659
Schwartz AR, Barnes M, Hillman D et al (2012) Acute upper airway responses to hypoglossal nerve stimulation during sleep in obstructive sleep apnea. Am J Respir Crit Care Med 185:420–426. https://doi.org/10.1164/rccm.201109-1614OC
Kezirian EJ, Goding GS, Malhotra A et al (2014) Hypoglossal nerve stimulation improves obstructive sleep apnea: 12-month outcomes. J Sleep Res 23:77–83. https://doi.org/10.1111/jsr.12079
Eastwood PR, Barnes M, Walsh JH et al (2011) Treating obstructive sleep apnea with hypoglossal nerve stimulation. Sleep 34:1479–1486. https://doi.org/10.5665/sleep.1380
Mwenge GB, Rombaux P, Dury M et al (2012) Targeted hypoglossal neurostimulation for obstructive sleep apnoea. A 1 year pilot Study. Eur Respir J Off J Eur Soc Clin Respir Physiol. https://doi.org/10.1183/09031936.00042412
Friedman M, Jacobowitz O, Hwang MS et al (2016) Targeted hypoglossal nerve stimulation for the treatment of obstructive sleep apnea: six-month results. Laryngoscope. https://doi.org/10.1002/lary.25909
Strollo PJ, Gillespie MB, Soose RJ et al (2015) Upper airway stimulation for obstructive sleep apnea: durability of the treatment effect at 18 months. Sleep 38:1593–1598. https://doi.org/10.5665/sleep.5054
Woodson BT, Strohl KP, Soose RJ et al (2018) Upper airway stimulation for obstructive sleep apnea: 5-year outcomes. Otolaryngol Neck Surg 159:194–202. https://doi.org/10.1177/0194599818762383
Gillespie MB, Soose RJ, Woodson BT et al (2017) Upper airway stimulation for obstructive sleep apnea: patient-reported outcomes after 48 months of follow-up. Otolaryngol Neck Surg 156:765–771. https://doi.org/10.1177/0194599817691491
Thaler E, Schwab R, Maurer J et al (2019) Results of the ADHERE upper airway stimulation registry and predictors of therapy efficacy. Laryngoscopelary. https://doi.org/10.1002/lary.28286
Ughratdar I, Kawsar KA, Mitchell R et al (2018) Use of pulsed radiofrequency energy device (PEAK plasmablade) in neuromodulation implant revisions. World Neurosurg 112:31–36. https://doi.org/10.1016/J.WNEU.2018.01.007
Funding
Apnex Medical Pivotal Study was financed by Apnex Medical Inc. Aftercare and evaluation of patient data in clinical follow-up—as presented here—was not financed.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by PA, SD, IF, AB and BW. Supervision was done by TP. The first draft of the manuscript was written by PA. Reviewing and editing of the manuscript was done by SD, TP and HO. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Philipp Arens P, Thomas Penzel, Ingo Fietze, Alexander Blau, Heidi Olze and Steffen Dommerich received financial support from ImThera Inc. and Apnex Medical Inc. within the framework of research projects related to hypoglossal nerve stimulation therapy. Philipp Arens received a speaker’s fee for an invited talk on behalf of Inspire Medical Inc.
Ethical approval
Procedures performed within the Apnex Pivotal Study were in accordance with the ethical standards of the national research committee (LAGeSo Berlin, 11/0326-ZS EK 11) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Consent for publication
Informed consent was obtained from all individual participants included in the study.
Code availability (software application or custom code)
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Arens, P., Penzel, T., Fietze, I. et al. Safety and effectiveness in explantation and re-implantation of hypoglossal nerve stimulation devices. Eur Arch Otorhinolaryngol 278, 477–483 (2021). https://doi.org/10.1007/s00405-020-06170-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-020-06170-w